No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Mesoblast's Gets FDA Acceptance of Application for Allogeneic Cellular Therapy
Mesoblast Shares Rise on Start of Late-Stage Trial For Low Back Pain Treatment
Express News | Mesoblast - US FDA Accepts Mesoblast's Bla Resubmission for Remestemcel-L
Mesoblast Starts Recruitment for Phase Three Low Back Pain Trial
Up 308% in 6 Months, Why Is the Mesoblast Share Price Tumbling Today?
AU Evening Wrap: ASX 200 Falls on Metal Stocks; Droneshield Rebounds
No Data